SK277758B6 - Transdermal therapeutic system - Google Patents

Transdermal therapeutic system Download PDF

Info

Publication number: SK277758B6
Authority: SK; Slovakia
Prior art keywords: active substance; transdermal therapeutic; therapeutic system; skin; distribution
Prior art date: 1987-07-09

Application number

SK4880-88A

Other languages

English (en)

Slovak (sk)

Inventor

Frank Becher

Original Assignee

Lohmann Therapie Syst Lts

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-07-09

Filing date

1988-07-05

Publication date

1994-12-07

1988-07-05 Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts

1994-12-07 Publication of SK277758B6 publication Critical patent/SK277758B6/sk

Links

230000001225 therapeutic effect Effects 0.000 title claims abstract description 25
239000010410 layer Substances 0.000 claims abstract description 22
239000013543 active substance Substances 0.000 claims description 81
238000009826 distribution Methods 0.000 claims description 36
239000011159 matrix material Substances 0.000 claims description 28
239000000853 adhesive Substances 0.000 claims description 16
239000007788 liquid Substances 0.000 claims description 13
239000012530 fluid Substances 0.000 claims description 5
239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 3
239000011505 plaster Substances 0.000 claims description 2
239000002904 solvent Substances 0.000 claims 1
239000012790 adhesive layer Substances 0.000 abstract description 8
239000000126 substance Substances 0.000 abstract description 8
238000003860 storage Methods 0.000 abstract description 2
239000004480 active ingredient Substances 0.000 description 11
239000000463 material Substances 0.000 description 7
-1 bufralol Chemical compound 0.000 description 5
239000011888 foil Substances 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 4
230000001070 adhesive effect Effects 0.000 description 4
229960002715 nicotine Drugs 0.000 description 4
SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 4
229940100640 transdermal system Drugs 0.000 description 4
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 3
229920001577 copolymer Polymers 0.000 description 3
239000003814 drug Substances 0.000 description 3
230000005484 gravity Effects 0.000 description 3
229910021653 sulphate ion Inorganic materials 0.000 description 3
DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
230000009471 action Effects 0.000 description 2
VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 2
229960005274 benzocaine Drugs 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
230000000694 effects Effects 0.000 description 2
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
229960004391 lorazepam Drugs 0.000 description 2
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
239000011976 maleic acid Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
239000000203 mixture Substances 0.000 description 2
KJONHKAYOJNZEC-UHFFFAOYSA-N nitrazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1 KJONHKAYOJNZEC-UHFFFAOYSA-N 0.000 description 2
229960001454 nitrazepam Drugs 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920001289 polyvinyl ether Polymers 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
BFUXUGOZJVHVMR-UHFFFAOYSA-N 1,1-dioxo-3,4-dihydro-2h-1$l^{6},2,4-benzothiadiazine-7-sulfonamide Chemical compound N1CNS(=O)(=O)C2=CC(S(=O)(=O)N)=CC=C21 BFUXUGOZJVHVMR-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
VSKJLJHPAFKHBX-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 VSKJLJHPAFKHBX-UHFFFAOYSA-N 0.000 description 1
229930183010 Amphotericin Natural products 0.000 description 1
QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 1
QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 1
241000723346 Cinnamomum camphora Species 0.000 description 1
108010000437 Deamino Arginine Vasopressin Proteins 0.000 description 1
BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
AGJUUQSLGVCRQA-SWOUQTJZSA-N Fungichromin Chemical compound CCCCC[C@@H](O)[C@@H]1[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)[C@@H](O)[C@H](O)\C(C)=C\C=C\C=C\C=C\C=C\[C@H](O)[C@@H](C)OC1=O AGJUUQSLGVCRQA-SWOUQTJZSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
AGJUUQSLGVCRQA-UHFFFAOYSA-N Pentamycin Natural products CCCCCC(O)C1C(O)CC(O)CC(O)CC(O)CC(O)CC(O)C(O)C(O)C(C)=CC=CC=CC=CC=CC(O)C(C)OC1=O AGJUUQSLGVCRQA-UHFFFAOYSA-N 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 1
XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
229960001301 amobarbital Drugs 0.000 description 1
229940009444 amphotericin Drugs 0.000 description 1
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
229940035674 anesthetics Drugs 0.000 description 1
230000000954 anitussive effect Effects 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
230000003556 anti-epileptic effect Effects 0.000 description 1
230000001532 anti-fungicidal effect Effects 0.000 description 1
230000003276 anti-hypertensive effect Effects 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
229960003965 antiepileptics Drugs 0.000 description 1
239000002220 antihypertensive agent Substances 0.000 description 1
229940127088 antihypertensive drug Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000003434 antitussive agent Substances 0.000 description 1
229940124584 antitussives Drugs 0.000 description 1
229940092705 beclomethasone Drugs 0.000 description 1
NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
229960003515 bendroflumethiazide Drugs 0.000 description 1
HDWIHXWEUNVBIY-UHFFFAOYSA-N bendroflumethiazidum Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1NC2CC1=CC=CC=C1 HDWIHXWEUNVBIY-UHFFFAOYSA-N 0.000 description 1
229960000686 benzalkonium chloride Drugs 0.000 description 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
CIJVBYRUFLGDHY-UHFFFAOYSA-N bucumolol Chemical compound O1C(=O)C=CC2=C1C(OCC(O)CNC(C)(C)C)=CC=C2C CIJVBYRUFLGDHY-UHFFFAOYSA-N 0.000 description 1
229950002568 bucumolol Drugs 0.000 description 1
229920005549 butyl rubber Polymers 0.000 description 1
229960000846 camphor Drugs 0.000 description 1
229930008380 camphor Natural products 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229960005091 chloramphenicol Drugs 0.000 description 1
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
229960001076 chlorpromazine Drugs 0.000 description 1
229960003120 clonazepam Drugs 0.000 description 1
DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
229960004022 clotrimazole Drugs 0.000 description 1
239000003218 coronary vasodilator agent Substances 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
WTYGAUXICFETTC-UHFFFAOYSA-N cyclobarbital Chemical compound C=1CCCCC=1C1(CC)C(=O)NC(=O)NC1=O WTYGAUXICFETTC-UHFFFAOYSA-N 0.000 description 1
229960004138 cyclobarbital Drugs 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
229960004281 desmopressin Drugs 0.000 description 1
NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
229960002768 dipyridamole Drugs 0.000 description 1
239000002934 diuretic Substances 0.000 description 1
229940030606 diuretics Drugs 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
229960002061 ergocalciferol Drugs 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
GLVVKKSPKXTQRB-UHFFFAOYSA-N ethenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC=C GLVVKKSPKXTQRB-UHFFFAOYSA-N 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
229960001395 fenbufen Drugs 0.000 description 1
ZPAKPRAICRBAOD-UHFFFAOYSA-N fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 description 1
PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
229960002428 fentanyl Drugs 0.000 description 1
229960003469 flumetasone Drugs 0.000 description 1
WXURHACBFYSXBI-GQKYHHCASA-N flumethasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O WXURHACBFYSXBI-GQKYHHCASA-N 0.000 description 1
229960002200 flunitrazepam Drugs 0.000 description 1
229940043075 fluocinolone Drugs 0.000 description 1
FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
229960002949 fluorouracil Drugs 0.000 description 1
229960002390 flurbiprofen Drugs 0.000 description 1
SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000003193 general anesthetic agent Substances 0.000 description 1
229960003711 glyceryl trinitrate Drugs 0.000 description 1
239000003163 gonadal steroid hormone Substances 0.000 description 1
239000011346 highly viscous material Substances 0.000 description 1
229960000890 hydrocortisone Drugs 0.000 description 1
229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
230000000147 hypnotic effect Effects 0.000 description 1
MPGBPFMOOXKQRX-UHFFFAOYSA-N indenolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=C1C=CC2 MPGBPFMOOXKQRX-UHFFFAOYSA-N 0.000 description 1
229950008838 indenolol Drugs 0.000 description 1
230000001788 irregular Effects 0.000 description 1
229960004194 lidocaine Drugs 0.000 description 1
229960004815 meprobamate Drugs 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
229960002009 naproxen Drugs 0.000 description 1
CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
229960001597 nifedipine Drugs 0.000 description 1
229960000988 nystatin Drugs 0.000 description 1
VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
229960000339 pentamycin Drugs 0.000 description 1
DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
229960002695 phenobarbital Drugs 0.000 description 1
229960002895 phenylbutazone Drugs 0.000 description 1
VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 description 1
229960002508 pindolol Drugs 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229960005205 prednisolone Drugs 0.000 description 1
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
238000003825 pressing Methods 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
239000000186 progesterone Substances 0.000 description 1
229960003387 progesterone Drugs 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
WTGQALLALWYDJH-WYHSTMEOSA-N scopolamine hydrobromide Chemical compound Br.C1([C@@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 WTGQALLALWYDJH-WYHSTMEOSA-N 0.000 description 1
229940125723 sedative agent Drugs 0.000 description 1
239000000932 sedative agent Substances 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
239000004945 silicone rubber Substances 0.000 description 1
231100000245 skin permeability Toxicity 0.000 description 1
239000011343 solid material Substances 0.000 description 1
229920006132 styrene block copolymer Polymers 0.000 description 1
SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 description 1
229960002673 sulfacetamide Drugs 0.000 description 1
239000000057 synthetic resin Substances 0.000 description 1
229920003002 synthetic resin Polymers 0.000 description 1
229960000195 terbutaline Drugs 0.000 description 1
230000001519 thymoleptic effect Effects 0.000 description 1
229960002044 tolmetin sodium Drugs 0.000 description 1
229960005294 triamcinolone Drugs 0.000 description 1
GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
229960002117 triamcinolone acetonide Drugs 0.000 description 1
JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 1
229960003386 triazolam Drugs 0.000 description 1
238000009827 uniform distribution Methods 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
235000001892 vitamin D2 Nutrition 0.000 description 1
239000011653 vitamin D2 Substances 0.000 description 1
MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
235000005282 vitamin D3 Nutrition 0.000 description 1
239000011647 vitamin D3 Substances 0.000 description 1
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
229940045997 vitamin a Drugs 0.000 description 1
229940021056 vitamin d3 Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Media Introduction/Drainage Providing Device (AREA)
Thermotherapy And Cooling Therapy Devices (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Percussion Or Vibration Massage (AREA)
Radiation-Therapy Devices (AREA)
Massaging Devices (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SK4880-88A 1987-07-09 1988-07-05 Transdermal therapeutic system SK277758B6 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19873722775 DE3722775A1 (de)	1987-07-09	1987-07-09	Transdermales therapeutisches system

Publications (1)

Publication Number	Publication Date
SK277758B6 true SK277758B6 (en)	1994-12-07

Family

ID=6331271

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK4880-88A SK277758B6 (en)	1987-07-09	1988-07-05	Transdermal therapeutic system

Country Status (28)

Country	Link
US (1)	US5066494A (fr)
EP (1)	EP0298297B1 (fr)
JP (1)	JP2694984B2 (fr)
KR (1)	KR970008118B1 (fr)
AT (1)	ATE72760T1 (fr)
AU (2)	AU1952688A (fr)
CA (1)	CA1295202C (fr)
CZ (1)	CZ277745B6 (fr)
DD (1)	DD291008A5 (fr)
DE (2)	DE3722775A1 (fr)
DK (1)	DK168032B1 (fr)
ES (1)	ES2038718T3 (fr)
FI (1)	FI92285C (fr)
GR (1)	GR3004238T3 (fr)
HR (1)	HRP920829A2 (fr)
HU (1)	HU203985B (fr)
IE (1)	IE61788B1 (fr)
IL (1)	IL86904A (fr)
MY (1)	MY103740A (fr)
NO (1)	NO167628C (fr)
NZ (1)	NZ225241A (fr)
PH (1)	PH25175A (fr)
PL (1)	PL163843B1 (fr)
PT (1)	PT87936B (fr)
SK (1)	SK277758B6 (fr)
WO (1)	WO1989000437A1 (fr)
YU (1)	YU46983B (fr)
ZA (1)	ZA884671B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5788983A (en) *	1989-04-03	1998-08-04	Rutgers, The State University Of New Jersey	Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
ES2017282A6 (es) *	1989-07-28	1991-01-16	Aguilera Franco Maria	Aposito para aplicaciones de substancias activas por via transcutanea con fines terapeuticos o cosmeticos.
DE4001034A1 (de) *	1990-01-16	1991-07-18	Eberhard Landau	Pflaster fuer die behandlung von warzen
JP3115625B2 (ja) *	1991-03-30	2000-12-11	帝國製薬株式会社	リドカイン含有外用貼付剤
US5707346A (en) *	1991-09-11	1998-01-13	Grastech, Inc.	System and method for performing soft tissue massage therapy
US5231977A (en) *	1991-09-11	1993-08-03	Graston David A	Tools and method for performing soft tissue massage
FR2686505A1 (fr) *	1992-01-29	1993-07-30	Lhd Lab Hygiene Dietetique	Procede de fabrication d'un pansement a bords amincis.
DK170792B1 (da) *	1992-08-27	1996-01-22	Coloplast As	Hudpladeprodukt til dosering af et eller flere medikamenter
DE4316751C1 (de) *	1993-05-19	1994-08-04	Lohmann Therapie Syst Lts	Verfahren und Vorrichtung zur Herstellung eines transdermalen Therapiesystems zur Verabreichung von Wirkstoffen an die Haut in Form eines flächigen Mehrkammer- bzw. Mehrkammerkanalsystems
DE59509232D1 (de) *	1994-02-18	2001-06-13	Drossapharm Ag Basel	Transdermales therapeutisches System
US5665452A (en) *	1994-03-03	1997-09-09	The Procter & Gamble Company	Three-dimensional, macroscopically expanded, apertured laminate webs
US5505958A (en) *	1994-10-31	1996-04-09	Algos Pharmaceutical Corporation	Transdermal drug delivery device and method for its manufacture
DE29514849U1 (de) *	1995-09-15	1995-11-16	Weyergans, Rudolf, 52355 Düren	Cellulitis-Pflaster
DE19600959A1 (de) *	1996-01-12	1997-07-17	Amp Holland	Faserabschnitt zur Verbindung zweier Faserenden und Verfahren zur Herstellung einer Verbindung zweier Faserenden
US5730721A (en) *	1996-01-25	1998-03-24	Vesture Corporation	Medical applicator and method
US8765177B2 (en) *	1997-09-12	2014-07-01	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
US7153845B2 (en) *	1998-08-25	2006-12-26	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
US6269820B1 (en)	1998-02-26	2001-08-07	Xomed Surgical Products, Inc.	Method of controlling post-operative leakage associated with tumescent liposuction
DE19900645C2 (de) *	1999-01-11	2003-03-20	Deotexis Inc	Transdermales therapeutisches System
DE29913844U1 (de)	1999-08-07	1999-10-07	Klocke Verpackungs-Service GmbH, 76356 Weingarten	Applikations-Packung
GB2353219B (en) *	1999-08-16	2004-02-11	Johnson & Johnson Medical Ltd	Easy to remove adhesive sheets
US6682757B1 (en)	2000-11-16	2004-01-27	Euro-Celtique, S.A.	Titratable dosage transdermal delivery system
CA2444883A1 (fr) *	2001-04-20	2002-10-31	Alza Corporation	Reseau de micro-projections avec revetement contenant un principe benefique
US20050118245A1 (en) *	2002-03-27	2005-06-02	Wilsmann Klaus M.	Assembled unit consisting of individually separable, transdermal, therapeutic systems
DE10213772A1 (de) *	2002-03-27	2003-10-09	Gruenenthal Gmbh	Zusammenhängende Einheit aus vereinzelbaren transdermalen therapeutischen Systemen
US7182955B2 (en) *	2003-04-30	2007-02-27	3M Innovative Properties Company	Abuse-resistant transdermal dosage form
US20040219195A1 (en) *	2003-04-30	2004-11-04	3M Innovative Properties Company	Abuse-resistant transdermal dosage form
US8790689B2 (en) *	2003-04-30	2014-07-29	Purdue Pharma L.P.	Tamper resistant transdermal dosage form
NZ542969A (en)	2003-04-30	2009-09-25	Purdue Pharma Lp	Tamper resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
US20050123507A1 (en) *	2003-06-30	2005-06-09	Mahmoud Ameri	Formulations for coated microprojections having controlled solubility
KR20060038407A (ko) *	2003-06-30	2006-05-03	알자 코포레이션	비휘발성 반대이온을 포함하는 코팅된 미세돌출부용 제제
US8524272B2 (en)	2003-08-15	2013-09-03	Mylan Technologies, Inc.	Transdermal patch incorporating active agent migration barrier layer
US9205062B2 (en)	2004-03-09	2015-12-08	Mylan Pharmaceuticals, Inc.	Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US20050202073A1 (en)	2004-03-09	2005-09-15	Mylan Technologies, Inc.	Transdermal systems containing multilayer adhesive matrices to modify drug delivery
DE102004020463A1 (de) *	2004-04-26	2005-11-10	Grünenthal GmbH	Wirkstoffabgabesystem aus einem wirkstoffhaltigen Pflaster und mindestens einem Wirkstoffabgaberegulierungsmittel
US20050255150A1 (en) *	2004-04-26	2005-11-17	Cassel Douglas R	Wound treatment patch for alleviating pain
EP1744683B1 (fr)	2004-05-13	2016-03-16	Alza Corporation	Appareil et procédé pour la délivrance transdermique d'agents à base d'hormone parathyroïde
EP1796651B1 (fr) *	2004-08-20	2015-05-20	3M Innovative Properties Company	Dispositif d'administration de medicament transdermique avec film protecteur translucide
DE102005004924A1 (de) *	2005-02-02	2006-08-03	Paul Hartmann Ag	Wundauflage
US20060188558A1 (en) *	2005-02-18	2006-08-24	Mylan Technologies, Inc.	Transdermal systems having control delivery system
US20100069887A1 (en) *	2008-09-16	2010-03-18	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Multiple chamber ex vivo adjustable-release final dosage form
US20100068278A1 (en) *	2008-09-16	2010-03-18	Searete Llc, A Limited Liablity Corporation Of The State Of Delaware	Ex vivo modifiable medicament release-associations
US8690841B2 (en) *	2009-07-09	2014-04-08	R. Gary Diaz	Wound care system
US9861590B2 (en) *	2010-10-19	2018-01-09	Covidien Lp	Self-supporting films for delivery of therapeutic agents
PH12013502067A1 (en)	2011-04-04	2014-01-13	Procter & Gamble	Personal care articles and methods
CN104202987B (zh)	2011-08-15	2017-09-01	宝洁公司	个人护理方法
WO2013025760A1 (fr)	2011-08-15	2013-02-21	The Procter & Gamble Company	Articles de soins personnels ayant de multiples zones contenant des compositions de soins personnels conformes
WO2014210229A1 (fr)	2013-06-27	2014-12-31	The Procter & Gamble Company	Compositions et articles de soins personnels
IL264911A (en)	2019-02-19	2020-08-31	Univ Ramot	Pad and method for its production

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA930668A (en) *	1969-04-01	1973-07-24	Zaffaroni Alejandro	Bandage for administering drugs
US3814095A (en) *	1972-03-24	1974-06-04	H Lubens	Occlusively applied anesthetic patch
IE54286B1 (en) *	1983-01-18	1989-08-16	Elan Corp Plc	Drug delivery device
US4622031A (en) *	1983-08-18	1986-11-11	Drug Delivery Systems Inc.	Indicator for electrophoretic transcutaneous drug delivery device
EP0156080B2 (fr) *	1984-03-05	1993-10-20	Nitto Denko Corporation	Préparation pharmaceutique adhésive du type à absorption percutanée
US4666441A (en) *	1985-12-17	1987-05-19	Ciba-Geigy Corporation	Multicompartmentalized transdermal patches
EP0252459A1 (fr) *	1986-07-07	1988-01-13	Schering Corporation	Système d'apport compartimenté agissant à travers la peau
US5032464A (en) *	1986-10-27	1991-07-16	Burlington Industries, Inc.	Electrodeposited amorphous ductile alloys of nickel and phosphorus

1987
- 1987-07-09 DE DE19873722775 patent/DE3722775A1/de not_active Withdrawn
- 1987-07-09 KR KR1019890700415A patent/KR970008118B1/ko not_active Expired - Fee Related
1988
- 1988-06-21 HU HU883744A patent/HU203985B/hu not_active IP Right Cessation
- 1988-06-21 US US07/327,810 patent/US5066494A/en not_active Ceased
- 1988-06-21 AU AU19526/88A patent/AU1952688A/en not_active Abandoned
- 1988-06-21 ES ES198888109852T patent/ES2038718T3/es not_active Expired - Lifetime
- 1988-06-21 DE DE8888109852T patent/DE3868549D1/de not_active Expired - Lifetime
- 1988-06-21 EP EP88109852A patent/EP0298297B1/fr not_active Expired - Lifetime
- 1988-06-21 WO PCT/DE1988/000370 patent/WO1989000437A1/fr not_active Ceased
- 1988-06-21 AT AT88109852T patent/ATE72760T1/de not_active IP Right Cessation
- 1988-06-21 JP JP63505040A patent/JP2694984B2/ja not_active Expired - Lifetime
- 1988-06-28 IL IL86904A patent/IL86904A/xx not_active IP Right Cessation
- 1988-06-29 PH PH37139A patent/PH25175A/en unknown
- 1988-06-30 ZA ZA884671A patent/ZA884671B/xx unknown
- 1988-06-30 NZ NZ225241A patent/NZ225241A/xx unknown
- 1988-07-02 MY MYPI88000732A patent/MY103740A/en unknown
- 1988-07-05 SK SK4880-88A patent/SK277758B6/sk unknown
- 1988-07-05 CZ CS884880A patent/CZ277745B6/cs not_active IP Right Cessation
- 1988-07-06 DD DD88317641A patent/DD291008A5/de not_active IP Right Cessation
- 1988-07-07 CA CA000571419A patent/CA1295202C/fr not_active Expired - Lifetime
- 1988-07-07 PT PT87936A patent/PT87936B/pt not_active IP Right Cessation
- 1988-07-08 IE IE208088A patent/IE61788B1/en not_active IP Right Cessation
- 1988-07-08 YU YU132688A patent/YU46983B/sh unknown
- 1988-07-08 PL PL88273619A patent/PL163843B1/pl unknown
1989
- 1989-03-06 NO NO890939A patent/NO167628C/no not_active IP Right Cessation
- 1989-03-07 FI FI891076A patent/FI92285C/fi not_active IP Right Cessation
- 1989-03-08 DK DK112989A patent/DK168032B1/da not_active IP Right Cessation
1992
- 1992-04-01 GR GR920400612T patent/GR3004238T3/el unknown
- 1992-08-20 AU AU21203/92A patent/AU662341B2/en not_active Ceased
- 1992-10-02 HR HRP920829AA patent/HRP920829A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
DK112989A (da)	1989-03-08
HUT53542A (en)	1990-11-28
PL273619A1 (en)	1989-03-20
HU203985B (en)	1991-11-28
IL86904A0 (en)	1988-11-30
FI92285B (fi)	1994-07-15
ES2038718T3 (es)	1993-08-01
EP0298297A1 (fr)	1989-01-11
FI891076L (fi)	1989-03-07
YU46983B (sh)	1994-09-09
JPH02501039A (ja)	1990-04-12
CA1295202C (fr)	1992-02-04
PH25175A (en)	1991-03-27
FI891076A0 (fi)	1989-03-07
NZ225241A (en)	1991-10-25
ZA884671B (en)	1989-03-29
PL163843B1 (pl)	1994-05-31
AU2120392A (en)	1992-11-19
DK112989D0 (da)	1989-03-08
FI92285C (fi)	1994-10-25
DD291008A5 (de)	1991-06-20
NO167628C (no)	1991-11-27
DE3868549D1 (en)	1992-04-02
HRP920829A2 (hr)	1994-04-30
KR890701164A (ko)	1989-12-19
IL86904A (en)	1993-08-18
AU662341B2 (en)	1995-08-31
IE61788B1 (en)	1994-11-30
ATE72760T1 (de)	1992-03-15
DE3722775A1 (de)	1989-01-19
WO1989000437A1 (fr)	1989-01-26
NO890939L (no)	1989-03-06
NO167628B (no)	1991-08-19
PT87936B (pt)	1993-09-30
CS488088A3 (en)	1992-12-16
GR3004238T3 (fr)	1993-03-31
JP2694984B2 (ja)	1997-12-24
MY103740A (en)	1993-09-30
AU1952688A (en)	1989-02-13
YU132688A (en)	1991-04-30
NO890939D0 (no)	1989-03-06
IE882080L (en)	1989-01-09
US5066494A (en)	1991-11-19
PT87936A (pt)	1989-06-30
CZ277745B6 (en)	1993-04-14
EP0298297B1 (fr)	1992-02-26
KR970008118B1 (ko)	1997-05-21
DK168032B1 (da)	1994-01-24

Publication	Publication Date	Title
SK277758B6 (en)	1994-12-07	Transdermal therapeutic system
JP2571563B2 (ja)	1997-01-16	経皮パツチ
US4810499A (en)	1989-03-07	Transdermal drug delivery system and method
KR970009723B1 (ko)	1997-06-17	생리학적 활성물질의 경피성 투여용 폐색체
US4624665A (en)	1986-11-25	Method of transdermal drug delivery
AU603531B2 (en)	1990-11-15	Device for administering an active agent to the skin or mucosa
US4687481A (en)	1987-08-18	Transdermal drug delivery system
US5683711A (en)	1997-11-04	Active ingredient patch
USRE34692E (en)	1994-08-09	Transdermal therapeutic system
KR910002250B1 (ko)	1991-04-08	피부에 유효약제를 조절하여 투여하는 유효약제-함유 플래스터
IE61305B1 (en)	1994-10-19	Transdermal therapeutic system, its use and process for the production thereof
EP0252459A1 (fr)	1988-01-13	Système d'apport compartimenté agissant à travers la peau
WO1990011065A1 (fr)	1990-10-04	Dispositif d'administration d'un agent actif sur la peau ou une muqueuse
CZ286264B6 (cs)	2000-03-15	Náplast jako transdermální terapeutický systém, způsob její výroby a její použití
JPH0693921B2 (ja)	1994-11-24	段階的な薬物放出を呈する皮膚経由医療薬
JPS6250447B2 (fr)	1987-10-24
JP2758002B2 (ja)	1998-05-25	貼付剤
SI8711587A (sl)	1996-10-31	Terapevtski sistem vnašanja aktivnih snovi na kozo
SK277842B6 (en)	1995-04-12	Therapeutic system for aplication of effective matters on skin method of its manufacture and its using
MXPA97005324A (en)	1998-07-03	Transdermal therapeutic system for the supply of (s) -3-methyl-5- (1-methyl-2-pirrolidenyl) -isoxazole or any of its salts pharmaceutically ap
MXPA98002799A (en)	1999-05-31	System of delivery of medication for two or massubstancias acti